1. Therapeutic siRNA: State-of-the-Art and Future Perspectives

   • Maik Friedrich
   • Achim Aigner

   Review Article Open access 23 August 2022 Pages: 549 - 571

   

2. Plant-Derived Human Vaccines: Recent Developments

   • Jennifer Stander
   • Sandiswa Mbewana
   • Ann E. Meyers

   Review Article 12 July 2022 Pages: 573 - 589

   

3. Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis

   • Mario Nuvolone
   • Alice Nevone
   • Giampaolo Merlini

   Review Article Open access 12 September 2022 Pages: 591 - 608

4. PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras

   • Jyotsana Madan
   • Vijay Kamal Ahuja
   • Sanjeev Giri

   Review Article 13 September 2022 Pages: 609 - 623

   

5. Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies

   • Hillel P. Cohen
   • Sohaib Hachaichi
   • Andrew Blauvelt

   Systematic Review Open access 26 July 2022 Pages: 625 - 637

   

6. The Nocebo Effect in a Non-Medical Switching Program from Originator to Biosimilar Infliximab in Inflammatory Bowel Disease

   • Krishneel Dutt
   • Ashish Srinivasan
   • Daniel Van Langenberg

   Original Research Article 12 August 2022 Pages: 639 - 644

   

7. Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study

   • Douglas J. Rupert
   • Alyssa M. Jordan
   • R. Craig Lefebvre

   Original Research Article 13 August 2022 Pages: 645 - 655

   

8. Real-World Effects of Biologics on Renal Function in Psoriatic Patients: A Retrospective Study

   • Chun-Bing Chen
   • Yu-Tung Huang
   • Ching-Chi Chi

   Original Research Article 22 August 2022 Pages: 657 - 666

   

9. Teserpaturev/G47Δ: First Approval

   • James E. Frampton

   AdisInsight Report 13 September 2022 Pages: 667 - 672